Choosing a biomanufacturing service organization: from the BSO perspective
Cell and Gene Therapy Insights · 26.03.2026 · 12 (2) · 203–213
DOI: 10.18609/cgti.2026.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 26.03.2026. Verfasst von Rohini Thevi Guntnur und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The wrong manufacturing partner costs more than time. A first-hand framework from the BSO side of the table — what sponsors must prepare, what a well-structured manufacturing partnership looks like, and where most projects go wrong before they even start.
Zitieren
APA
Guntnur, R. T., III, R. R., Higdon, J., Cacchillo, D., & Zamilpa, R. (2026). Choosing a biomanufacturing service organization: from the BSO perspective. Cell and Gene Therapy Insights, 12(2), 203–213. https://doi.org/10.18609/cgti.2026.028
Vancouver
Guntnur RT, III RR, Higdon J, Cacchillo D, Zamilpa R. Choosing a biomanufacturing service organization: from the BSO perspective. Cell and Gene Therapy Insights. 2026;12(2):203–213. doi:10.18609/cgti.2026.028
BibTeX
@article{Guntnur2026,
author = {Guntnur, Rohini Thevi and III, Ray Rendon and Higdon, Joseph and Cacchillo, Deidre and Zamilpa, Rogelio},
title = {Choosing a biomanufacturing service organization: from the BSO perspective},
journal = {Cell and Gene Therapy Insights},
year = {2026},
volume = {12},
number = {2},
pages = {203–213},
doi = {10.18609/cgti.2026.028}
}
EUVIMED